AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34697401 — intervention group
Group type: COMPARATOR
Intervention: Baseline indoxyl sulfate abundance
Number of subjects: 196
Study 34697401 — intervention group
Group type: COMPARATOR
Intervention: Baseline indole abundances
Number of subjects: 196
Study 34697401 — intervention group
Group type: COMPARATOR
Intervention: Changes in symptoms
Number of subjects: 196
Study 33319490 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACHES-LEM
Number of subjects: 117
Study 33319490 — intervention group
Group type: COMPARATOR
Intervention: F2FT
Number of subjects: 117
Study 33252929 — intervention group
Group type: EXPERIMENTAL
Intervention: rBWL + Peer
Number of subjects: 278
Study 33252929 — intervention group
Group type: EXPERIMENTAL
Intervention: rBWL + Mentor
Number of subjects: 278
Study 33252929 — intervention group
Group type: COMPARATOR
Intervention: rBWL
Number of subjects: 278
Study 36400420 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum ultrasound (IPUS) for labor progress assessment, avoiding digital exams as much as possible.
Number of subjects: 182
Study 36400420 — intervention group
Group type: COMPARATOR
Intervention: Control group with regular protocol for labor progress assessment.
Number of subjects: 182
Study 33930381 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form Reproductive Coercion Scale
Number of subjects: 628
Study 32020567 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (subtotal or gross-total resection)
Number of subjects: 16
Study 32020567 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (imatinib, bevacizumab)
Number of subjects: 16
Study 32020567 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT (Stereotactic Body Radiotherapy)
Number of subjects: 16
Study 32020567 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive multi-modality treatment options
Number of subjects: 16
Study 35364066 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy for H pylori eradication (n=817)
Number of subjects: 1630
Study 35364066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=813)
Number of subjects: 1630
Study 35364066 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy for H pylori eradication (n=625 with successful eradication)
Number of subjects: 1630
Study 35364066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=527 with persistent H pylori infection)
Number of subjects: 1630
Study 35364066 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy for H pylori eradication (n=625)
Number of subjects: 1630
Study 33953315 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 26
Study 33953315 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 26
Study 32187680 — intervention group
Group type: COMPARATOR
Intervention: Invasive placebo interventions
Number of subjects: 0
Study 32187680 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical interventions
Number of subjects: 0
Study 37258943 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g whole almonds daily during the intervention period
Number of subjects: 43
Study 37258943 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 43
Study 33122092 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation Treatment (SDT) for 48 hours
Number of subjects: 36
Study 33122092 — intervention group
Group type: COMPARATOR
Intervention: Control group (48 hours of normal sleep)
Number of subjects: 36
Study 32502559 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier group (2-4 days postoperatively)
Number of subjects: 64
Study 32502559 — intervention group
Group type: COMPARATOR
Intervention: Later group (7 days postoperatively)
Number of subjects: 64
Study 35477594 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Amphetamine Transdermal System (d-ATS) 5 mg/9 h, with possible dose increase to 10 mg/9 h, 15 mg/9 h, and 20 mg/9 h during the study
Number of subjects: 110
Study 35477594 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Amphetamine Transdermal System (d-ATS)
Number of subjects: 110
Study 35477594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Penalized AFT model including the main effect of covariate (Penalized, Eq_in)
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate AFT model excluding the main effect of covariate (Univariate, Eq_ex)
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage adaptive design
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Responder subgroup
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate AFT models
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Penalized AFT models
Number of subjects: 0
Study 33849830 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive design significance levels
Number of subjects: 0
Study 35122668 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at a dose of 400 IU/d (vD-400 group)
Number of subjects: 72
Study 35122668 — intervention group
Group type: COMPARATOR
Intervention: Placebo (liquid product without vitamin D3)
Number of subjects: 72
Study 35122668 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (vD-400 and placebo)
Number of subjects: 72
Study 35122668 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with severe vitamin D deficiency
Number of subjects: 72
Study 33966439 — intervention group
Group type: EXPERIMENTAL
Intervention: Embracing breast milk sucking (EBMS)
Number of subjects: 96
Study 32866396 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ)
Number of subjects: 31
Study 32866396 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 31
Study 32347688 — intervention group
Group type: EXPERIMENTAL
Intervention: FineVision POD F
Number of subjects: 45
Study 32347688 — intervention group
Group type: EXPERIMENTAL
Intervention: RayOne Trifocal
Number of subjects: 45
Study 32347688 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrysof IQ PanOptix
Number of subjects: 45
Study 32347688 — intervention group
Group type: COMPARATOR
Intervention: PODF
Number of subjects: 45
Study 32347688 — intervention group
Group type: COMPARATOR
Intervention: RayOne
Number of subjects: 45
Study 32347688 — intervention group
Group type: COMPARATOR
Intervention: PanOptix
Number of subjects: 45
Study 36303179 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) at a rate of 60 L/min and a concentration of 100% (n = 87)
Number of subjects: 176
Study 36303179 — intervention group
Group type: COMPARATOR
Intervention: Facemask at a rate of 6 L/min and a concentration of 100% (n = 89)
Number of subjects: 176
Study 36303179 — intervention group
Group type: COMPARATOR
Intervention: Facemask (n = 89)
Number of subjects: 176
Study 33472722 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain intake (half of grain servings from whole grain foods daily for 6 weeks)
Number of subjects: 44
Study 33472722 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention (no whole grain foods for 6 weeks)
Number of subjects: 44
Study 33442853 — intervention group
Group type: COMPARATOR
Intervention: 532-nm Q-switched Nd:YAG laser, 3 sessions at 1-month intervals
Number of subjects: 40
Study 33442853 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm low-fluence Q-switched Nd:YAG laser, 6 sessions at 2-week intervals
Number of subjects: 40
Study 33461756 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed frozen embryo transfer (n = 357)
Number of subjects: 1136
Study 33461756 — intervention group
Group type: COMPARATOR
Intervention: Natural cycle FET (modified natural cycle FET and true natural cycle FET)
Number of subjects: 1136
Study 32233922 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the term 'stuttering' during evaluations
Number of subjects: 141
Study 32233922 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased experience with a specific speech-language population
Number of subjects: 141
Study 32233922 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowing a person who stutters
Number of subjects: 141
Study 34347945 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (n=43)
Number of subjects: 63
Study 34347945 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (n=20)
Number of subjects: 63
Study 34347945 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF treatment (both etanercept and adalimumab)
Number of subjects: 63
Study 34347945 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional B cells
Number of subjects: 63
Study 33481484 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD oil (150 mg POST, 24 h, 48 h)
Number of subjects: 13
Study 33481484 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC: POST, 24 h, 48 h)
Number of subjects: 13
Study 33121501 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP/FF/G (100/6/10 µg in TRIMARAN; 200/6/10 µg in TRIGGER)
Number of subjects: 0
Study 33121501 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP/FF/G
Number of subjects: 0
Study 33121501 — intervention group
Group type: COMPARATOR
Intervention: BDP/FF
Number of subjects: 0
Study 33377987 — intervention group
Group type: EXPERIMENTAL
Intervention: rFVIIIFc
Number of subjects: 227
Study 33377987 — intervention group
Group type: COMPARATOR
Intervention: BAY 94-9027
Number of subjects: 227
Study 33377987 — intervention group
Group type: COMPARATOR
Intervention: BAY 94-9027 Q7D
Number of subjects: 227
Study 33346061 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue covarine containing toothpaste (BCT)
Number of subjects: 0
Study 33346061 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste without pigment (CT)
Number of subjects: 0
Study 33346061 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' satisfaction with treatment results
Number of subjects: 0
Study 33346061 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' evaluation of tooth color
Number of subjects: 0
Study 32239318 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 polymorphic short tandem repeats (STRs) genetic markers
Number of subjects: 464
Study 35675081 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency coronary angiogram (CAG)
Number of subjects: 279
Study 35675081 — intervention group
Group type: COMPARATOR
Intervention: Delayed coronary angiogram (CAG)
Number of subjects: 279
Study 32917424 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE Healthy Lifestyles TEEN Program
Number of subjects: 169
Study 35924247 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent HPV vaccine
Number of subjects: 20
Study 35924247 — intervention group
Group type: COMPARATOR
Intervention: Nonavalent HPV vaccine
Number of subjects: 20
Study 35924247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 20
Study 34763504 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with cisplatin intracavitary perfusion scheme
Number of subjects: 86
Study 34763504 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin intracavitary perfusion scheme
Number of subjects: 86
Study 32662724 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary task selection procedure allowing participants to choose which task to perform on each trial.
Number of subjects: 0
Study 32662724 — intervention group
Group type: EXPERIMENTAL
Intervention: Color selection group
Number of subjects: 0
Study 32662724 — intervention group
Group type: COMPARATOR
Intervention: Shape selection group
Number of subjects: 0
Study 35544384 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine (AZA) + Lenalidomide (LEN)
Number of subjects: 0
Study 35544384 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine (AZA) + Valproic Acid (VPA)
Number of subjects: 0
Study 35544384 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine (AZA) + Idarubicin (IDA)
Number of subjects: 0
Study 35544384 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine (AZA) alone
Number of subjects: 0
Study 34144047 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab IV 300 mg every 8 weeks
Number of subjects: 769
Study 34044564 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 pneumoperitoneum at varying pressures (15-16 mmHg)
Number of subjects: 424
Study 34044564 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 pneumoperitoneum at varying pressures
Number of subjects: 424
Study 32352912 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay health worker intervention (2 educational sessions on HEPA)
Number of subjects: 640
Study 32352912 — intervention group
Group type: COMPARATOR
Intervention: Colorectal cancer comparison (2 educational sessions)
Number of subjects: 640
Study 33573589 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeying through Dementia (JtD) intervention, consisting of both group and individual sessions, with a therapeutic dose of 10 out of 16 sessions.
Number of subjects: 0
Study 34753085 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic treatment
Number of subjects: 30
Study 34753085 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study 34753085 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 30
Study 34636734 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP‐Webinar intervention (6-week structured, remote access group intervention)
Number of subjects: 196
Study 34636734 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 196
Study 34933143 — intervention group
Group type: COMPARATOR
Intervention: taVNS
Number of subjects: 43
Study 35061237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement containing probiotics and botanical extract (group II)
Number of subjects: 114
Study 35061237 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical extracts (group III)
Number of subjects: 114
Study 35061237 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (group IV)
Number of subjects: 114
Study 35061237 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group I)
Number of subjects: 114
Study 35061237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement (group II)
Number of subjects: 114
Study 35238144 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.25% w/w finasteride spray (1-4 sprays; 50-200 μl/day) for 24 weeks
Number of subjects: 0
Study 35238144 — intervention group
Group type: COMPARATOR
Intervention: Once-daily finasteride 1 mg oral tablet for 24 weeks
Number of subjects: 0
Study 35238144 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily finasteride 1% topical gel for 6 months
Number of subjects: 0
Study 35238144 — intervention group
Group type: COMPARATOR
Intervention: Once-daily finasteride 1 mg oral tablet for 6 months
Number of subjects: 0
Study 35238144 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily finasteride 0.25% topical solution for 7 days
Number of subjects: 0
Study 35238144 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical finasteride
Number of subjects: 0
Study 33917366 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding Education and Support Intervention (BFESI)
Number of subjects: 468
Study 33917366 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 468
Study 32365000 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Hyperthermia exposure programme (HTC)
Number of subjects: 34
Study 32365000 — intervention group
Group type: COMPARATOR
Intervention: Light Intermittent Exercise (LIE) programme
Number of subjects: 34
Study 34160906 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic studies on brain-enriched plasma proteins specific for SCD and silent cerebral infarcts.
Number of subjects: 0
Study 34160906 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbiased proteomic studies
Number of subjects: 0
Study 32295716 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin (bolus 0.75 mg/kg followed by an infusion 1.75 mg/kg/h for the duration of the procedure)
Number of subjects: 1812
Study 32295716 — intervention group
Group type: COMPARATOR
Intervention: Heparin (bolus 70 U/kg)
Number of subjects: 1812
Study 33462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean ABCA1_B methylation
Number of subjects: 211
Study 33462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean ABCA1_A methylation in the middle tertile of BMI
Number of subjects: 211
Study 33462393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean ABCA1_A methylation together with age and gender
Number of subjects: 211
Study 32418236 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal reduction
Number of subjects: 308
Study 32418236 — intervention group
Group type: COMPARATOR
Intervention: No occlusal reduction
Number of subjects: 308
Study 32418236 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 308
Study 34739584 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated anesthesia control system
Number of subjects: 56
Study 34739584 — intervention group
Group type: COMPARATOR
Intervention: Manual anesthesia control by anesthesiologists
Number of subjects: 56
Study 34739584 — intervention group
Group type: COMPARATOR
Intervention: Automated anesthesia control system vs Manual anesthesia control
Number of subjects: 56
Study 33170506 — intervention group
Group type: COMPARATOR
Intervention: Picture Option Grid (n = 248)
Number of subjects: 571
Study 33170506 — intervention group
Group type: COMPARATOR
Intervention: Option Grid (n = 66)
Number of subjects: 571
Study 35778539 — intervention group
Group type: EXPERIMENTAL
Intervention: TBRS training (triweekly for 12 weeks)
Number of subjects: 90
Study 35778539 — intervention group
Group type: COMPARATOR
Intervention: Control group (NC group)
Number of subjects: 90
Study 34022462 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography (QCT) measurements of thoracic spine BMD
Number of subjects: 60
Study 36209240 — intervention group
Group type: EXPERIMENTAL
Intervention: MoCA Blind/Telephone
Number of subjects: 0
Study 36209240 — intervention group
Group type: COMPARATOR
Intervention: In-person MoCA assessment
Number of subjects: 0
Study 33501810 — intervention group
Group type: EXPERIMENTAL
Intervention: CHB patients
Number of subjects: 25
Study 33501810 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals (CN group)
Number of subjects: 25
Study 34050877 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium citrate administration
Number of subjects: 65
Study 34050877 — intervention group
Group type: COMPARATOR
Intervention: No potassium citrate administration (Control)
Number of subjects: 65
Study 32616589 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg·day‐1)
Number of subjects: 251
Study 32616589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 35647191 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercise group (12-week progressive yoga exercise program starting at postpartum week 1)
Number of subjects: 116
Study 35647191 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 116
Study 33957293 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT-SE (combined compensatory cognitive training and supported employment)
Number of subjects: 116
Study 33957293 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 116
Study 37287522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat plant-based diet
Number of subjects: 244
Study 37287522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 244
Study 34333648 — intervention group
Group type: COMPARATOR
Intervention: 0% SL hay
Number of subjects: 25
Study 34333648 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% SL hay
Number of subjects: 25
Study 34333648 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% SL hay
Number of subjects: 25
Study 34333648 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% SL hay
Number of subjects: 25
Study 34333648 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% SL hay
Number of subjects: 25
Study 32791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital storytelling intervention based on rational emotive behaviour therapy (REBT)
Number of subjects: 171
Study 32791690 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 171
Study 32652863 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval walking training (IT) - 3 sessions of 60 minutes per week for 4 months, with 3-minute intervals of slow and fast walking at 40% and 70% peak energy expenditure
Number of subjects: 40
Study 32652863 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval walking training (IT)
Number of subjects: 40
Study 32652863 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34978107 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater endoscopic mucosal resection (UEMR)
Number of subjects: 210
Study 34978107 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic mucosal resection (CEMR)
Number of subjects: 210
Study 33661121 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid web-based training program (GET.ON Panic)
Number of subjects: 92
Study 33661121 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 92
Study 35618377 — intervention group
Group type: EXPERIMENTAL
Intervention: Class norm-framed imagined contact (n=88)
Number of subjects: 269
Study 35618377 — intervention group
Group type: EXPERIMENTAL
Intervention: Family norm-framed imagined contact (n=49)
Number of subjects: 269
Study 35618377 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious in-group norm-framed imagined contact (n=51)
Number of subjects: 269
Study 35618377 — intervention group
Group type: COMPARATOR
Intervention: Standard imagined contact (n=80)
Number of subjects: 269
Study 34262619 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib + JOINS
Number of subjects: 0
Study 34262619 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib + Placebo
Number of subjects: 0
Study 33046839 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT (LDCT) screening
Number of subjects: 0
Study 33046839 — intervention group
Group type: EXPERIMENTAL
Intervention: LDCT-based screening programmes
Number of subjects: 0
Study 33884701 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated dynamic overlay mattress on top of a viscoelastic foam mattress
Number of subjects: 70